INSMED Inc
INSM· Nasdaq
INSMINSMED Inc
Filed Feb 23, 2023 · 10-K · 54 days after period end · 0001104506-23-000009
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $59.30M | $56.12M | $41.42M | $45.71M |
| Net Income | -$160.12M | -$112.98M | -$102.21M | -$52.99M |
| EPS Diluted | — | — |
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
| — |
| -$0.59 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 23, 2023 · 54 d after period end
